HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Abstract
To determine the relation between the presence of donor DNA polymerase and e antigen, and recipient hepatitis, we tested, under code, serums from a controlled trial of hepatitis B immune globulin used to treat individuals accidentally inoculated with HBs Ag-positive blood. All recipients lacked antibody to HBs Ag. In 29 of 31 donors, both polymerase and e were in perfect agreement; both demonstrated a highly significant correlation with recipient hepatitis (P less than 0.001). DNA polymerase/e-negative blood did not cause hepatitis. Blood containing polymerase or e antigen did not cause hepatitis in six of 31 and four of 18 recipients, respectively. Hepatitis did not correlate with transaminase or duration of antigenemia in the donor. Polymerase and e appear to be indicators of the relative infectivity of HBs Ag-positive serum, particularly after small-volume exposure. They may be important determinants in assessing infectivity of chronic carriers of HBs Ag and in evaluating efficacy of hepatitis B immune globulin and hepatitis B vaccines.
AuthorsH J Alter, L B Seeff, P M Kaplan, V J McAuliffe, E C Wright, J L Gerin, R H Purcell, P V Holland, H J Zimmerman
JournalThe New England journal of medicine (N Engl J Med) Vol. 295 Issue 17 Pg. 909-13 (Oct 21 1976) ISSN: 0028-4793 [Print] United States
PMID967200 (Publication Type: Journal Article)
Chemical References
  • Hepatitis B Antigens
Topics
  • Acute Disease
  • Blood Donors
  • Carrier State
  • Chronic Disease
  • Hepatitis B (blood, immunology, transmission)
  • Hepatitis B Antigens (analysis)
  • Humans
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: